Waqoo Inc.

2026/08/21 Updated
Market Cap: $53.1M (¥8.4B)
Stock Price: $14.91 (¥2,370)
Exchange Rate: 1 USD = ¥158.98

Financial Summary / Earnings Report

Based on the financial summary, explains revisions to the FY2026 earnings outlook, the positioning of the D2C business, the introduction of shareholder benefits, and other measures to optimize the business structure and engage investors.

Importance:
Page Updated: August 20, 2026
IR Disclosure Date: August 20, 2026

Key Figures

  • Revision forecast (as of May)
  • This revision
  • Outlook going forward

AI要約

Section Heading

This material redefines the D2C business as a cash-generation function and outlines a shift to a platform-based revenue model, while stressing the transition of the business structure to the Medical Support business. It first explains the upward revision to the FY2026 earnings forecast and the changes in contribution between segments that underlie this revision. Next, it details concrete measures to enhance shareholder value, such as the introduction of a shareholder benefits program, and outlines future IR event plans.

Section 2 Heading

This year's earnings outlook is expected to be lifted by multiple factors, including an upward revision. By expanding D2C sales and creating synergies with medical-related businesses, the company aims to improve overall profitability. The introduction of a shareholder benefit program is positioned as a measure to strengthen shareholder returns and pursue long-term value for shareholders. Upcoming events such as results briefing and IR events are clearly noted, and the policy to strengthen information disclosure to institutional investors is outlined.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Waqoo

Company overview · Stock price · Financial data · All IR

View company page →